While one study reported poor OS and progression-free survival in RHOAG17V -mutated AITL [38], another study revealed that RHOA mutation-negative cases had shorter relapse-free survival and showed a trend towards shorter overall survival [39]. The gene discussed is RHOA; the disease is angioimmunoblastic T-cell lymphoma.